The National Institutes of Health (NIH) stroke scale is a standardized neurologic examination developed to quantitate the patient's deficits in clinical trials for new stroke therapies. It is used on admission to determine patient eligibility for thrombolytic therapy, throughout the acute hospital stay, and at 3 months to assess neurologic recovery. The NIH stroke scale scores correlates with initial infarct volume, cerebral perfusion, and functional outcome.